Reply to "Rituximab in thrombocytopenic purpura..."

Main Article Content

Miguel A. Zambrano-Velarde
<p>Servicio de Hematolog&iacute;a,&nbsp;Divisi&oacute;n de Medicina Interna, Hospital Civil de Guadalajara &ldquo;Dr. Juan I. Menchaca&rdquo;, Universidad de Guadalajara, Jalisco</p>

Daniel De la O-Peña
<p>Servicio de Medicina Interna, Hospital Civil de Guadalajara &ldquo;Dr. Juan I. Menchaca&rdquo;, Guadalajara, Jalisco</p>

Quetzalcóatl Chávez-Peña
<p>Servicio de Medicina Interna, Hospital Civil de Guadalajara &ldquo;Dr. Juan I. Menchaca&rdquo;, Guadalajara, Jalisco</p>

Martín Bedolla-Barajas
<p>Servicio de Alergia e Inmunolog&iacute;a Cl&iacute;nica, Hospital Civil de Guadalajara &ldquo;Dr. Juan I. Menchaca&rdquo;, Guadalajara, Jalisco</p>

Keywords

Purpura, Thrombocytopenic, Rituximab

Abstract

No abstract.

Abstract 89 | PDF (Spanish) Downloads 17

References

Panchal S, Khare M, Moorthy A, Samanta A. Catch me if you can: a national survey of rheumatologists and obstetricians on the use of DMARDs during pregnancy. Rheumatol Int 2012 Mar 27.

 

Ton E, Tekstra J, Hellmann PM, Nuver-Zwart IH, Bijlsma JW. Safety of rituximab therapy during twins’ pregnancy. Rheumatology (Oxford) 2011;50(4):806-808.

 

Chambers C, Koren G, Tutuncu ZN, Johnson D, Jones KL. Are new agents used to treat rheumatoid arthritis safe to take during pregnancy? Organization of Teratology Infor-mation Specialists (OTIS) study. Can Fam Physician 2007;53(3):409-412. Disponible en http://www.ncbi. nlm.nih.gov/pmc/articles/PMC1949070/

 

Vinet E, Pineau C, Gordon C, Clarke AE, Bernatsky S. Biologic therapy and pregnancy outcomes in women with rheumatic diseases. Arthritis Rheum 2009;61(5):587-592. Disponible en http://onlinelibrary.wiley.com/doi/10.1002/art.24462/abstract;jsessionid=4D184B827E4032EDE0B 8FCAD522A1E3E.d03t03

 

Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes after maternal exposure to rituximab. Blood 2011;117(5):1499-1506. Disponible en http://bloodjournal.hematologylibrary.org/content/117/5/1499. long

Article Sidebar

PDF (Spanish)
Issue
Vol. 50 No. 4 (2012): July-August
Section
Letter to the Editor

Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.

How to Cite

1.
Zambrano-Velarde MA, De la O-Peña D, Chávez-Peña Q, Bedolla-Barajas M. Reply to "Rituximab in thrombocytopenic purpura. ". Rev Med Inst Mex Seguro Soc [Internet]. 2017 Jan. 24 [cited 2025 Jul. 15];50(4):353-4. Available from: https://revistamedica.imss.gob.mx/index.php/revista_medica/article/view/1169